ClinicalTrials.gg
SuspendedNCT06286904Updated Oct 8, 2026

Sleep Position Pattern Recording

An observational study in Pregnant Women, sponsored by Myant Medical Corp.. Suspended at 1 site in Canada. Open to female participants, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-08.

Sponsored by Myant Medical Corp. · Observational

How we know

Why this study was suspended
Funding and regulatory issues.
Updated Oct 8, 2026Now SuspendedPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
52
Sex
Female
01

Study summary

The main goal of this study is to validate the accuracy of the body position detection by non-invasive wearable monitors (Skiin garments, Myant Medical Corp) during sleep in pregnant participants. This is a first step towards examining the association between maternal sleep position and fetal growth.

Read the detailed description

Individuals who are eligible to the study and provided consent to participate will be asked to:

  1. Wear the Skiin Garment system for the duration of their time in the hospital (minimum 1 nights until they are discharged from hospital).
  2. Complete a study completion questionnaire about their experience with the device and the study.

The Skiin Garment system is composed by biosensing garments presented in different form factors (bra, chest band, or underwear). It captures physiological metrics and relay information from a pod to local hub with Bluetooth.

The true body position will be obtained using visual observations and cameras.

02

Conditions studied

  • Pregnant Women

Keywords

  • sleep
  • wearable electronic devices
  • Pregnant Women
  • Posture
03

In context

Lead sponsor

Myant Medical Corp. is the lead sponsor of 7 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Pregnant women admitted in the antenatal in-patient clinic at McMaster University Medical Centre for greater than 24 hours.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Assigned female at birth
  • Currently pregnant
  • Admission to MUMC Antenatal Clinic with anticipation of being admitted for greater than 24 hours
  • Able and willing to provide to participate

Exclusion criteria

Exclusion Criteria:

  • Unestablished gestational dating (based on first-trimester ultrasound)
  • Known maternal cardiac or pulmonary disorder
  • Known sleep disorders (i.e., sleep apnea, periodic limb movement disorder, etc.)
  • Known fetal chromosomal or structural abnormalities
  • Known highly sensitive skin/skin sensitivities to textile electrodes
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
52 participants (estimated)
Patient registry
No

Groups and cohorts

  • Sleep position detection

    Accuracy of Skiin Garment system for detecting sleep position of pregnant womem.

    Device: Skiin Garment system

Interventions

  • DeviceSkiin Garment system

    Individuals will be asked to wear a Skiin Garment system for the duration of their hospitalization (minimum one day).The system will collect accelerometer, ECG, temperature, heart rate, steps and sleep metrics data if enable. Then, they will be asked to answer a questionnaire about their experiences with the device and the study.

06

What researchers measure

Primary outcomes

  1. Accuracy of Skiin Garment system for detecting sleep position of pregnant women

    Sleep position will be identified through the Skiin Garment system via accelerometry, and compared to visual confirmation of sleep position.

    Time frame: Recorded during the night, during 6 to 8 hours.

Secondary outcomes

  1. Questionnaire on wearable device invasiveness and satisfaction

    Pregnant women will be asked to answer a questionnaire at the end of their participation in the study. It contains questions related to patients' experience wearing the Skiin Garment system, including invasiveness and satisfaction. This is an ad-hoc questionnaire titled "SPV\_Satisfaction\_Questionnaire\_v1\_2023-04-03" containing 20 questions: 14 questions use a Likert scale design, 3 questions are single choice answer, and 3 questions are open-ended questions. Results are not reported as a total score on a scale but descriptive statistics will be used individually per question.

    Time frame: One time point, on the morning after one night wearing the Skiin Garment system

  2. Participant recruitment rate

    Recruitment rate will be calculated as the number of participants who consent to participant divided by the number of participants who consent to be contacted.

    Time frame: From the beginning to the end of the recruitment, up to 1 year.

  3. Participant retention rate

    The retention rate will be calculated as the number of participants who remain in the study divided by the number of participants who initially consent to participate.

    Time frame: From the beginning to the end of participation, up to 1 year.

07

Study locations

1 site
  • McMaster University
    Hamilton, Ontario L8S 4K1, Canada
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Ran from Apr 2024 to primary completion in Apr 2024, 0 months.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 8, 2026: primary completion Dec 2024 → Apr 2024 and completion Mar 2025 → Oct 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 16, 2024
First posted
Feb 29, 2024
StartActual
Apr 1, 2024
Primary completionActual
Apr 1, 2024was Dec 2024
CompletionEst.
Oct 2, 2026was Mar 2025
Last update
Oct 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Suspended Funding and regulatory issues.
changed Oct 8, 2026
Primary completion
Dec 1, 2024→Apr 1, 2024 (actual)
Oct 8, 2026
Study completion
Mar 30, 2025→Oct 2, 2026
Oct 8, 2026
Secondary outcomes
1 description edited
What changed in the outcomes
  • DescriptionQuestionnaire on wearable device invasiveness and satisfaction: how it is measured was reworded
Oct 8, 2026
Show all 1 update
  1. Oct 8, 2026
    Not yet recruiting→Suspended
    Why stopped Funding and regulatory issues.
    Primary completion Dec 1, 2024→Apr 1, 2024 (now actual)
    Study completion Mar 30, 2025→Oct 2, 2026
    Secondary outcomes 1 description edited
    What changed in the outcomes
    • DescriptionQuestionnaire on wearable device invasiveness and satisfaction: how it is measured was reworded
    + 3 other changes: verification date, contact details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06286904
Lead sponsor
Myant Medical Corp.
Collaborators
McMaster University
Responsible party
Sponsor
First posted
Feb 29, 2024
Start date
Apr 1, 2024
Primary completion
Apr 1, 2024
Completion
Oct 2, 2026 (estimated)
Last update
Oct 8, 2026

Study contacts

Eran Ashwal
principal investigator · McMaster University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is suspended, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion